Roundup.

US Jury Punishes Bayer With $81 Million Damages Ruling in Latest Glyphosate Cancer Trial

A jury in the U.S. has found for the second time that Bayer/Monsanto’s glyphosate-based herbicide Roundup causes cancer and awarded $81 Million in damages on Wednesday to the plaintiff Edwin Hardeman. The jury in San Francisco federal court said that Bayer/Monsanto was liable for plaintiff Edwin Hardeman’s non-Hodgkin’s lymphoma

March 28, 2019 | Source: Sustainable Pulse | by

A jury in the U.S. has found for the second time that Bayer/Monsanto’s glyphosate-based herbicide Roundup causes cancer and awarded $81 Million in damages on Wednesday to the plaintiff Edwin Hardeman.

The jury in San Francisco federal court said that Bayer/Monsanto was liable for plaintiff Edwin Hardeman’s non-Hodgkin’s lymphoma.

It awarded $5.6 million in compensatory damages, $75 million in punitive damages and $200,000 in medical expenses to Hardeman after finding that Roundup was defectively designed, that Monsanto failed to warn of the herbicide’s cancer risk and that the company acted negligently.

After the verdict, Hardeman told reporters he was “overwhelmed.” “It hasn’t sunk in yet,” he said.

Hardeman’s case was considered a bellwether trial to help determine the range of damages and define settlement options for the more than 760 other federal cases pending in the same court before U.S. District Judge Vince Chhabria.